High Court rejects Nurofen tablet manufacturer’s appeal against $6 million penalty
The High Court’s decision to uphold the $6 million penalty against Reckitt Benckiser (Australia) Pty Ltd, the manufacturer of Nurofen tablets, serves as an important reminder for traders to ensure all claims made in their marketing and advertising materials do not extend beyond the capabilities of the goods and services they provide. In particular, the Australian Competition and Consumer Commission has stated its intention to target large companies that engage in misleading or deceptive conduct towards consumers, and to continue to advocate for higher penalties under the Australian Consumer Law. Considering this, we strongly recommend all such companies review and consider the accuracy of their marketing and promotional materials.
Thanks to Kelly Dickson for this update – http://www.mk.com.au/our-people/kelly-dickson/